Table 1 Clinical Characteristics of Patients at the Baseline.
| Â | Allicor | Placebo | ||||
|---|---|---|---|---|---|---|
Variable | All | Men | Women | All | Men | Women |
| Â | (n = 26) | (n = 14) | (n = 12) | (n = 25) | (n = 14) | (n = 11) |
Age, years | 56.7 ± 1.8 | 53.6 ± 1.9 | 60.3 ± 2.9 | 56.3 ± 1.7 | 52.6 ± 1.9 | 60.9 ± 2.4$ |
SBP, mm Hg | 134.2 ± 2.8 | 130.4 ± 3.8 | 138.8 ± 3.9 | 130.8 ± 3.1 | 129.3 ± 4.4 | 132.7 ± 4.3 |
DBP, mm Hg | 82.5 ± 1.9 | 82.1 ± 2.6 | 82.9 ± 2.9 | 81.0 ± 1.7 | 81.4 ± 2.5 | 80.5 ± 2.4 |
BMI, kg/m2 | 27.0 ± 0.9 | 27.2 ± 1.2 | 26.8 ± 1.5 | 27.9 ± 0.9 | 27.3 ± 1.0 | 28.6 ± 1.6 |
DM, n | 0 | 0 | 0 | 0 | 0 | 0 |
LVH, n | 3 | 2 | 1 | 3 | 2 | 1 |
MI, n | 17 | 12 | 5 | 13 | 10 | 3 |
Smoking, n | 8* | 7 | 1 | 4 | 4 | 0 |